chr12-20862972-C-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_019844.4(SLCO1B3):c.727+118C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.12 in 515,374 control chromosomes in the GnomAD database, including 4,654 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.10 ( 1126 hom., cov: 32)
Exomes 𝑓: 0.13 ( 3528 hom. )
Consequence
SLCO1B3
NM_019844.4 intron
NM_019844.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.10
Genes affected
SLCO1B3 (HGNC:10961): (solute carrier organic anion transporter family member 1B3) This gene encodes a liver-specific member of the organic anion transporter family. The encoded protein is a transmembrane receptor that mediates the sodium-independent uptake of endogenous and xenobiotic compounds and plays a critical role in bile acid and bilirubin transport. Mutations in this gene are a cause of Rotor type hyperbilirubinemia. Alternative splicing of this gene and the use of alternative promoters results in transcript variants encoding different isoforms that differ in their tissue specificity. [provided by RefSeq, Mar 2017]
SLCO1B3-SLCO1B7 (HGNC:54403): (SLCO1B3-SLCO1B7 readthrough) This locus represents naturally occurring readthrough transcription between the neighboring SLCO1B3 (solute carrier organic anion transporter family member 1B3) and SLCO1B7 (solute carrier organic anion transporter family member 1B7 (putative)) genes on chromosome 12. The readthrough transcript encodes a protein that shares sequence identity with both the upstream and downstream genes. [provided by RefSeq, Jun 2019]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.151 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLCO1B3 | NM_019844.4 | c.727+118C>G | intron_variant | Intron 8 of 15 | ENST00000381545.8 | NP_062818.1 | ||
SLCO1B3-SLCO1B7 | NM_001371097.1 | c.727+118C>G | intron_variant | Intron 6 of 15 | NP_001358026.1 | |||
SLCO1B3 | NM_001349920.2 | c.643+118C>G | intron_variant | Intron 6 of 13 | NP_001336849.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLCO1B3 | ENST00000381545.8 | c.727+118C>G | intron_variant | Intron 8 of 15 | 2 | NM_019844.4 | ENSP00000370956.4 | |||
SLCO1B3-SLCO1B7 | ENST00000540229.1 | c.727+118C>G | intron_variant | Intron 6 of 15 | 2 | ENSP00000441269.1 |
Frequencies
GnomAD3 genomes AF: 0.105 AC: 15917AN: 152012Hom.: 1128 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
15917
AN:
152012
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.127 AC: 46083AN: 363246Hom.: 3528 AF XY: 0.128 AC XY: 24214AN XY: 189904 show subpopulations
GnomAD4 exome
AF:
AC:
46083
AN:
363246
Hom.:
AF XY:
AC XY:
24214
AN XY:
189904
Gnomad4 AFR exome
AF:
AC:
284
AN:
10080
Gnomad4 AMR exome
AF:
AC:
1034
AN:
12476
Gnomad4 ASJ exome
AF:
AC:
2096
AN:
10752
Gnomad4 EAS exome
AF:
AC:
6
AN:
26118
Gnomad4 SAS exome
AF:
AC:
1184
AN:
18132
Gnomad4 FIN exome
AF:
AC:
3528
AN:
34816
Gnomad4 NFE exome
AF:
AC:
34606
AN:
227650
Gnomad4 Remaining exome
AF:
AC:
2789
AN:
20984
Heterozygous variant carriers
0
1841
3681
5522
7362
9203
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
316
632
948
1264
1580
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.105 AC: 15912AN: 152128Hom.: 1126 Cov.: 32 AF XY: 0.100 AC XY: 7448AN XY: 74382 show subpopulations
GnomAD4 genome
AF:
AC:
15912
AN:
152128
Hom.:
Cov.:
32
AF XY:
AC XY:
7448
AN XY:
74382
Gnomad4 AFR
AF:
AC:
0.0291014
AN:
0.0291014
Gnomad4 AMR
AF:
AC:
0.108986
AN:
0.108986
Gnomad4 ASJ
AF:
AC:
0.192795
AN:
0.192795
Gnomad4 EAS
AF:
AC:
0.00173678
AN:
0.00173678
Gnomad4 SAS
AF:
AC:
0.0681724
AN:
0.0681724
Gnomad4 FIN
AF:
AC:
0.102135
AN:
0.102135
Gnomad4 NFE
AF:
AC:
0.15344
AN:
0.15344
Gnomad4 OTH
AF:
AC:
0.135633
AN:
0.135633
Heterozygous variant carriers
0
718
1436
2155
2873
3591
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
174
348
522
696
870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
114
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at